Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients

South African Medical Journal

Volumn 102, Issue 6, 2012, Pages 363-366

  Harris, Tashneem ^a,b   Bardien, Soraya ^c   Simon Schaaf, H ^c   Petersen, Lucretia ^b   de Jong, Greetje ^c   Fagan, Johannes J ^b  

^a Kimberley Hospital Complex   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CAPREOMYCIN; KANAMYCIN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN; AMINOGLYCOSIDE;

ADOLESCENT; ADULT; AGED; AMINOGLYCOSIDE INDUCED HEARING LOSS; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; OTOTOXICITY; HEARING LOSS; PROSPECTIVE STUDY; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

AMINOGLYCOSIDES; COHORT STUDIES; HEARING LOSS; HUMANS; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84870153608     PISSN: 02569574     EISSN: 20785135     Source Type: Journal    
DOI: 10.7196/samj.4964     Document Type: Article

References (14)

1. Wells CD, Cegielsk JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196(Suppl 1): S86-S107. [http://dx.doi.org/10.1086/518665] [PMID:17624830]
2. World Health Organization. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. Emergency Update 2008. Geneva: World Health Organization, 2008. WHO/HTM/ TB/2008.402. http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf (accessed 20 February 2010).
3. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm 2007;13:119-126. [http://dx.doi. org/10.2174/138161207779313731][PMID:17266591]
4. Moore RD, Smith CR, Lietman PS. Risk factors for the development of auditory ototoxicty in patients receiving aminoglycosides. J Infect Dis 1984;149(1):23-30. [http://dx.doi.org/10.1093/infdis/149.1.23] [PMID:6693788]
5. Bardien S, Human H, Harris T, et al. A rapid method for the detection of five known mutations associated with aminoglycoside induced deafness. BMC Med Genet 2009;10:2. http://www. biomedcentral.com/1471-2350/10/2 (accessed 30 March 2010).
6. Human H, Hagen CM, Bardien S, et al. Investigation of mitochondrial sequence variants associated with aminogloycoside-induced ototoxicity in South African TB patients on aminoglycosides. Biochem Biophys Res Commun 2010;393;751-756. [http:dx.doi.org/10.1086/j.bbrc.2010.02.075] [PMID:20171168]
7. Tang HY, Hutcheson T, Neill S, et al. Genetic susceptibility to aminolgycoside ototoxicity: how many are at risk? Genet Med 2002;4(5):336-339. [http://dx.doi.org/10.1097/00125817-200209000-00004] [PMID:12394346].
8. Lu J, Qian Y, Li Z, et al. Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness associated 12S rRNA 1555A>G mutation. Mitochondrion 2010;10(1):69-81. [http:dx.doi. org/10.1016/j.mito.2009.09.007][PMID:19818876]
9. Duggal P, Sarkar M. Audiological monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear Nose Throat Disorders 2007;7:2. http:// www.biomedcentral.com/1472-6815/7/5 (accessed 30 March 2010). [http://dx.doi.org/10.1186/1472-6815-7-5][PMID:17997841]
10. Torun T, Gungor G, Ozmen I, et al. Side effects associated with the treatment of multi-drug resistant tuberculosis. Int J Tuberc Lung Dis 2005;9(12):1373-1377. [PMID:16468160]
11. Khoza-Shangase K. Highly active antiretroviral therapy: Does it sound toxic? J Pharm Bioall Sci 2011;3:142-153. [http://dx.doi.org/10.4103/0975-7406.76494] [PMID:21430965]
12. Campbell K. Audiologic monitoring for ototoxicity. In: Roland P, Rutka J, eds. Ototoxicity. Hamilton, Canada: B C Decker Publishers, 2004:153-160.
13. Swart S. Draft Report: Modernisation of Audiology Sevices, Western Cape 2010. Cape Town: Department of Health, Western Cape, 2010:41-46.
14. Khoza-Shangase K, Mupawose A, Mlangeni NP. Ototoxic effects of tuberculosis treatments: How aware are patients? AJPP 2009;3(8):391-399. http://www.academicjournals.org/ajpp (accessed 7 March 2012).